Search
![](https://static.wixstatic.com/media/6516fb_1f603cd42cdb441d82f291afa97825ca~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,lg_1,q_30,blur_30,enc_auto/6516fb_1f603cd42cdb441d82f291afa97825ca~mv2.jpg)
![UK MHRA: 150-Day Assessment for National Applications](https://static.wixstatic.com/media/6516fb_1f603cd42cdb441d82f291afa97825ca~mv2.jpg/v1/fill/w_399,h_192,fp_0.50_0.50,q_90,enc_auto/6516fb_1f603cd42cdb441d82f291afa97825ca~mv2.jpg)
Sharan Murugan
- Nov 1, 2022
- 1 min
UK MHRA: 150-Day Assessment for National Applications
Recently the UK's Medicines and Healthcare products Regulatory Agency (MHRA) updated their "150-day assessment for national applications...
157 views0 comments
![](https://static.wixstatic.com/media/nsplsh_c9263cbc71034780bda1e1332e87c664~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_c9263cbc71034780bda1e1332e87c664~mv2.jpg)
![USFDA's Notice: CMC Development & Readiness Pilot Program](https://static.wixstatic.com/media/nsplsh_c9263cbc71034780bda1e1332e87c664~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_c9263cbc71034780bda1e1332e87c664~mv2.jpg)
Sharan Murugan
- Nov 1, 2022
- 1 min
USFDA's Notice: CMC Development & Readiness Pilot Program
Recently in a new program announced by the Food and Drug Administration (USFDA), a limited number of applicants will be able to...
18 views0 comments
![](https://static.wixstatic.com/media/nsplsh_426e929833dc4f2db57de98abbf71b75~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_426e929833dc4f2db57de98abbf71b75~mv2.jpg)
![DRAP Guidelines: Preparation of Summary of Product Characteristics (SmPC)](https://static.wixstatic.com/media/nsplsh_426e929833dc4f2db57de98abbf71b75~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_426e929833dc4f2db57de98abbf71b75~mv2.jpg)
Sharan Murugan
- Oct 27, 2022
- 1 min
DRAP Guidelines: Preparation of Summary of Product Characteristics (SmPC)
The Drug Regulatory Authority of Pakistan (DRAP) released a finalized guideline "Preparation of Summary of Product Characteristics...
15 views0 comments
![](https://static.wixstatic.com/media/6516fb_dc128e30bc864c34823f2c59f4ded2c1~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/6516fb_dc128e30bc864c34823f2c59f4ded2c1~mv2.jpg)
![USFDA Guidance: Developing & Responding to Deficiencies - Least Burdensome Provisions](https://static.wixstatic.com/media/6516fb_dc128e30bc864c34823f2c59f4ded2c1~mv2.jpg/v1/fill/w_399,h_295,fp_0.50_0.50,q_90,enc_auto/6516fb_dc128e30bc864c34823f2c59f4ded2c1~mv2.jpg)
Sharan Murugan
- Oct 27, 2022
- 1 min
USFDA Guidance: Developing & Responding to Deficiencies - Least Burdensome Provisions
Earlier today (28-October-2022) the USFDA released final guidance on "Developing and Responding to Deficiencies in Accordance with the...
73 views0 comments
![](https://static.wixstatic.com/media/nsplsh_731aee6f09ef4ac88232e2d2cec350cf~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_731aee6f09ef4ac88232e2d2cec350cf~mv2.jpg)
![SFDA Guidance: Good Regulatory Practice & National Diagnostic Reference Levels](https://static.wixstatic.com/media/nsplsh_731aee6f09ef4ac88232e2d2cec350cf~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_731aee6f09ef4ac88232e2d2cec350cf~mv2.jpg)
Sharan Murugan
- Oct 27, 2022
- 1 min
SFDA Guidance: Good Regulatory Practice & National Diagnostic Reference Levels
Earlier today (27-October-2022) the Saudi Food & Drug Authority (SFDA) released updated guidance on "Good Regulatory Practice". A Good...
20 views0 comments